MYMX

Mymetics Corp.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 12/09/2016
Contact Info
  • co Mymetics S.A.
  • Biopole
  • Route de la Corniche, 4
  • Epalinges 1066
  • Switzerland

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000927761
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 1994
Employees 10 a/o Dec 31, 2015
Company Officers/Contacts
Ronald Kempers President, CEO
Sylvain Fleury CSO
Toon Stegmann Chief Scientific Officer
Carmelina Mahrer Director, Fin.
Company Directors
Ulrich Burkhard
Thomas Staehelin
Ernest M. Stern
Company Notes
  • Formerly=ICHOR Corp. until 7-01
  • Formerly=PDG Remediation, Inc. until 1-97
Service Providers
Accounting/Auditing Firm
Peterson Sullivan LLP
601 Union St.
Suite 2300
Seattle, WA, 98101
United States

Legal Counsel
Akerman LLP
One SE 3rd Avenue
Suite 2700
Miami, FL, 33131
United States

Investor Relations Firm
Dynamics Group SA
Rue de Caroubiers 21
CH 1227 Carouge
Switzerland

MYMX Security Details
Share Structure
Market Value1 $6,014,401 a/o Dec 09, 2016
Authorized Shares 1,000,000,000 a/o Mar 29, 2016
Outstanding Shares 303,757,622 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 91,064,968 a/o Mar 29, 2016
Par Value 0.01
Transfer Agent(s)
Interwest Transfer Co., Inc.
Shareholders
Shareholders of Record 611 a/o Mar 28, 2016
Short Selling Data
Short Interest 1,529 (118.43%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security